Monoclonal Antibody Treatment for Systemic Lupus Erythematosus
NCT00046774
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
NIH
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
MRA 003 US
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)